Micromonospora: Difference between revisions
From ActinoBase
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Morphology== | ==Morphology== | ||
On a plate, <i>Micromonospora</i> can be identified as red/orange/brown colonies which develop black pigmentation over time. Under the microscope, <i>Micromonospora</i> can be observed as unbranched vegetative hyphae which develop into branched reprodutive hyphae in possession of young individual sporophores<sup>[1]</sup>. | On a plate, <i>Micromonospora</i> can be identified as red/orange/brown colonies which develop black pigmentation over time. Under the microscope, <i>Micromonospora</i> can be observed as unbranched vegetative hyphae which develop into branched reprodutive hyphae in possession of young individual sporophores<sup>[1]</sup>. | ||
[[File:Oligo_3.png|200 px|]] | |||
==Secondary metabolites== | ==Secondary metabolites== | ||
| Line 9: | Line 11: | ||
=References= | =References= | ||
# SUAREZ, J. E. & HARDISSON, C. 1985. Morphological characteristics of colony development in Micromonospora chalcea. J Bacteriol, 162, 1342-4. | |||
Revision as of 15:05, 30 August 2019
Micromonospora
In the family Micromonosporaceae, best known for making gentamicin which can be used to treat Gram-negative bacterial infections.
Morphology
On a plate, Micromonospora can be identified as red/orange/brown colonies which develop black pigmentation over time. Under the microscope, Micromonospora can be observed as unbranched vegetative hyphae which develop into branched reprodutive hyphae in possession of young individual sporophores[1].
Secondary metabolites
Micromonospora produce a number of bioactive secondary metabolites, including the aminoglycoside gentamicin and the anticancer agent calicheamicin.
References
- SUAREZ, J. E. & HARDISSON, C. 1985. Morphological characteristics of colony development in Micromonospora chalcea. J Bacteriol, 162, 1342-4.
